Current Studies
Eosinophilic Esophagitis
Eosinophilic Esophagitis is a chronic immune system disease. Typically presents with difficulty swallowing or food becoming lodged in the esophagus. We are currently seeking participants 18 years or older who have been diagnosed with EOE or have a subjective reporting of four or more episodes of dysphagia over a two week period. Participants receive all study related care and medication at no cost. No insurance is required.
Ulcerative Colitis
Ulcerative Colitis is a chronic inflammatory bowel disease that is distinguished by inflammation of the large intestine (rectum and colon). We currently have several different studies a participant can choose from. Participants must be 18 years or older and have a diagnosis of UC for at least 3 months. Click the link below to learn more about involvement in UC studies.
Nonalcoholic steatohepatitis (NASH)
NASH is a chronic and progressive disease caused by fat deposition in the liver, which cause inflammation and damage of the liver. If not treated, NASH can develop into cirrhosis, liver failure and cancer, which are all severe diseases. It is unknown why some people develop NASH and others don’t, but people with certain medical conditions such as type 2 diabetes, obesity and high cholesterol are at a higher risk of developing this disease. Interested to learn more about the NASH studies offered and if one may be a good fit for you? Click the link below to learn more about the NASH studies we offer.
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome is a common disorder that affects the large intestine. Symptoms including bloating, gas, diarrhea, constipation or both and abdominal pain. We are currently enrolling in an IBS with abdominal Pain. Participants must be 18-70 years of age with a clinical diagnosis of IBS-C or IBS-D.
Clostridium difficile
Clostridium difficile (C. diff) is a bacteria that causes people to become sick with severe diarrhea and colitis. It is common for people to have recurrent C. diff infections. In most cases, people develop C. diff while on or after taking antibiotics. In some cases, C. diff can be fatal. The Louisiana Research Center is currently conducting some C. diff studies. To learn more about those studies, click the button below: